Pain
Conditions
Interventions
This is a randomized, controlled, single-blind clinical trial conducted with a probabilistic sample of 74 patients undergoing cardiovascular surgical procedures. Participants were randomly assigned to
Sponsors
Rodrigo Assis Neves Dantas Dantas
Universidade Federal do Rio Grande do Norte
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria will be based on patients aged 18 years or older; admitted to the Hemodynamics Unit of Heart Hospital of Natal for first-time ACTP-type cardiovascular surgical procedures requiring removal of an arterial introducer via the femoral approach; and undergoing an elective cardiovascular procedure.
Exclusion criteria
Exclusion criteria: Exclusion criteria include patients with chronic pain; continuous use of analgesics, anxiolytics, or antidepressants; neurological and/or cognitive problems that compromise comprehension and use of the scale at the appropriate time; olfactory impairment or respiratory disease; and allergies or sensitivity to chamomile.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction is expected to be observed upon removal of the femoral arterial introducer, as assessed using the Visual Analogue Scale.;It is expected that anxiety will decrease following the removal of the femoral arterial introducer, as assessed by the State-Trait Anxiety Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that vital signs will stabilize (blood pressure, oxygen saturation (SpO2), heart rate, and respiratory rate).;The absence of sweating, paleness, and vocal or facial expression of pain is expected. | — |
Countries
Brazil
Contacts
Public ContactRodrigo Dantas
Universidade Federal do Rio Grande do Norte
Outcome results
None listed